Cargando…
Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes
The generation of clinical good manufacturing practices (GMP)-grade adeno-associated virus (AAV) vectors requires purification strategies that support the generation of vectors of high purity, and that exhibit a good safety and efficacy profile. To date, most reported purification schemas are seroty...
Autores principales: | Nass, Shelley A., Mattingly, Maryellen A., Woodcock, Denise A., Burnham, Brenda L., Ardinger, Jeffrey A., Osmond, Shayla E., Frederick, Amy M., Scaria, Abraham, Cheng, Seng H., O’Riordan, Catherine R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767896/ https://www.ncbi.nlm.nih.gov/pubmed/29349097 http://dx.doi.org/10.1016/j.omtm.2017.12.004 |
Ejemplares similares
-
Highly Efficient Ultracentrifugation-free Chromatographic Purification of Recombinant AAV Serotype 9
por: Tomono, Taro, et al.
Publicado: (2018) -
High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography
por: Florea, Michael, et al.
Publicado: (2022) -
Aurintricarboxylic acid increases yield of HSV-1 vectors
por: Pechan, Peter, et al.
Publicado: (2014) -
Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle
por: Pacak, Christina A, et al.
Publicado: (2008) -
The impact of minimally oversized adeno-associated viral vectors encoding human factor VIII on vector potency in vivo
por: Kyostio-Moore, Sirkka, et al.
Publicado: (2016)